Skip to main content
. 2019 Jul 5;14(7):e0219398. doi: 10.1371/journal.pone.0219398

Fig 8. The mode of activity of agents used in this study.

Fig 8

In untreated cells, pro-survival BCL-2, BCL-XL, and MCL-1 bind to inhibit the function of pro-apoptotic BAX and BAK. When cells are treated by combinations, these pro-apoptotic proteins are released and activated to efficiently induce apoptosis.